Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2023
Benzinga · 21h ago
Venus Concept Earnings Perspective: Return On Capital Employed
Benzinga · 21h ago
Ladenburg Thalmann Maintains Buy on Venus Concept, Lowers Price Target to $2.2
Benzinga · 22h ago
Maxim Group Downgrades Venus Concept to Hold
Benzinga · 23h ago
--Ladenburg Thalmann Adjusts Price Target on Venus Concept to $2.20 From $3.25, Maintains Buy Rating
--Ladenburg Thalmann Adjusts Price Target on Venus Concept to $2.20 From $3.25, Maintains Buy Rating
MT Newswires · 1d ago
BTIG Releases a Buy Rating on Venus Concept (VERO)
TipRanks · 1d ago
--Maxim Downgrades Venus Concept to Hold From Buy
--Maxim Downgrades Venus Concept to Hold From Buy
MT Newswires · 1d ago
Earnings Scheduled For March 27, 2023
Benzinga · 2d ago
BRIEF-Venus Concept Announces Fourth Quarter And Fiscal Year 2022 Financial Results
Reuters · 2d ago
Venus Concept GAAP EPS of -$0.14 in-line, revenue of $24.29M beats by $0.39M
Seeking Alpha · 2d ago
Venus Concept Q4 EPS $(0.14), Inline, Sales $24.29M Beat $23.77M Estimate
Benzinga · 2d ago
-- Earnings Flash (VERO) VENUS CONCEPT Posts Q4 Revenue $24.3M, vs. Street Est of $23.9M
-- Earnings Flash (VERO) VENUS CONCEPT Posts Q4 Revenue $24.3M, vs. Street Est of $23.9M
MT Newswires · 2d ago
Venus Concept Q4 2022 Earnings Preview
Seeking Alpha · 4d ago
Venus Concept's Earnings: A Preview
Benzinga · 4d ago
Venus Concept Has Launched Its Latest Generation Of ARTAS iX, Which Is Now Broadly Available To Physicians Specializing In Hair Transplantation Worldwide
Benzinga · 03/20 11:09
Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga · 02/13 19:12
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 02/13 17:30
Maxim Group Sticks to Their Buy Rating for Venus Concept (VERO)
TipRanks · 02/08 20:35
Venus Concept Lays Off Around 18% Of Its Workforce, Expects Q4 Earnings Below Street Estimates
Benzinga · 02/07 15:12
BTIG Remains a Buy on Venus Concept (VERO)
TipRanks · 02/07 13:25
Webull provides a variety of real-time VERO stock news. You can receive the latest news about Venus Concept Inc through multiple platforms. This information may help you make smarter investment decisions.
About VERO
Venus Concept Inc. is a global medical technology company. The Company develops, commercializes, and sells minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. Its products and services include main console and applicators/handpieces, marketing supplies and kits, consumables and disposables, replacement applicators/handpieces, and others. It has developed and commercialized 11 technology platforms, including its ARTAS and NeoGraft systems. Its medical aesthetic technology platform is for a variety of indications, including treatment of facial wrinkles in certain skin types, temporary reduction of appearance of cellulite, non-invasive fat reduction (lipolysis) in the abdomen and flanks for certain body types and relief of minor muscle aches and pains in jurisdictions around the world. Venus Viva, Venus Viva MD, Venus Legacy, Venus Concept, Venus Versa, Venus Fiore, Venus Freedom, and others are trademarks of the Company.